ArticleBioinformatics (Oxford, England)2025
AntigenApp: a laboratory data management system for nanobody generation and sequence analysis.
Article in Bioinformatics (Oxford, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
motivationNanobodies are single domain antibodies derived from the unique heavy chain-only immunoglobulins of the camelid family, and have broad applications in biosciences, including as imaging and diagnostic agents. The generation of nanobodies is a multi-stage experimental process for which we have developed AntigenApp a laboratory data management system for nanobody generation and sequence analysis.
resultsAntigenApp is a web application and database built to capture data generated during all steps of the nanobody discovery pipeline and to provide built-in analysis capabilities of the experimental results. This includes enzyme-linked immunosorbent assay optical density measurements, sequencing results, nanobody domain labelling, and search/clustering capabilities using protein BLAST. The tool incorporates a standardized naming convention that is automatically applied to nanobodies stored in the database and we envisage the tool being of interest to the wider nanobody community for in-house use. AVAILABILITY AND IMPLEMENTATION: AntigenApp is available from https://github.com/rosalindfranklininstitute/antigen-app under the Apache 2.0 licence and published https://doi.org/10.5281/zenodo.17397055.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.